Fungal Infection |
Clinical Diagnosis |
Treatment |
Dermatophytosis (Tinea) |
- Diagnosis: Skin, hair, or nail infection caused by dermatophytes (e.g., Trichophyton, Microsporum).
- Scaling, itching, and ring-shaped lesions on skin (ringworm).
- Onychomycosis (nail infections) result in thickened, discolored nails.
- Diagnosis confirmed by skin scrapings and microscopy, or fungal culture.
|
- Topical antifungals: Terbinafine or clotrimazole for localized infections.
- Oral antifungals: Terbinafine or itraconazole for more extensive skin infections or onychomycosis.
|
Candidiasis (Mucosal and Cutaneous) |
- Diagnosis: White patches on mucosa (thrush), red irritated skin in intertriginous areas, or diaper rash in infants.
- Common after antibiotic or steroid use, or in immunocompromised individuals.
- Confirmed by clinical examination or swabs with microscopy and culture.
|
- Topical antifungals: Nystatin or clotrimazole for oral or cutaneous infections.
- Oral antifungals: Fluconazole for more severe or recurrent infections.
|
Aspergillosis |
- Diagnosis: Pulmonary or sinus infections caused by Aspergillus species. Can cause allergic bronchopulmonary aspergillosis (ABPA), aspergilloma (fungus ball), or invasive aspergillosis in immunocompromised patients.
- Confirmed by imaging (CT scan), culture, and antigen testing (galactomannan).
|
- ABPA: Steroids and itraconazole.
- Invasive aspergillosis: Voriconazole or amphotericin B.
|
Cryptococcosis |
- Diagnosis: Pulmonary or CNS infection caused by Cryptococcus neoformans, typically affecting immunocompromised individuals (e.g., HIV/AIDS).
- Presents with pneumonia or cryptococcal meningitis.
- Confirmed by CSF analysis (India ink stain or cryptococcal antigen test) and culture.
|
- Meningitis: Amphotericin B + flucytosine, followed by fluconazole.
- Pulmonary infection: Fluconazole.
|
Histoplasmosis |
- Diagnosis: Lung infection caused by inhalation of Histoplasma capsulatum, common in the Ohio and Mississippi River valleys. Can cause chronic pulmonary infection or disseminated disease in immunocompromised patients.
- Confirmed by urine antigen testing, serology, or biopsy with culture.
|
- Mild/moderate infection: Itraconazole.
- Severe/disseminated infection: Amphotericin B followed by itraconazole.
|
Coccidioidomycosis (Valley Fever) |
- Diagnosis: Lung infection caused by Coccidioides species, found in the southwestern U.S. (Arizona, California). Symptoms include fever, cough, and chest pain.
- Confirmed by serology, culture, or biopsy.
|
- Mild infection: Usually self-limiting, may require no treatment.
- Severe or disseminated infection: Fluconazole or itraconazole; amphotericin B for severe cases.
|
Blastomycosis |
- Diagnosis: Lung infection caused by Blastomyces dermatitidis, found in the eastern U.S. and parts of Canada. Can cause chronic pneumonia or disseminated infection involving skin, bones, and genitourinary tract.
- Confirmed by culture or histopathology.
|
- Mild/moderate infection: Itraconazole.
- Severe infection: Amphotericin B followed by itraconazole.
|
Pneumocystis pneumonia (PCP) |
- Diagnosis: Opportunistic lung infection caused by Pneumocystis jirovecii, seen in immunocompromised patients (e.g., HIV/AIDS). Symptoms include fever, cough, and dyspnea.
- Confirmed by bronchoalveolar lavage (BAL) and PCR testing.
|
- Treatment: Trimethoprim-sulfamethoxazole (TMP-SMX) is the drug of choice.
- Prophylaxis: TMP-SMX for high-risk individuals (e.g., HIV patients with CD4 count <200).
|